Benzinga · Sep 18, 2026
TD Cowen Reiterates Buy on Surgery Partners, Maintains $19 Price Target
TD Cowen analyst Ryan Langston reiterates Surgery Partners (NASDAQ:SGRY) with a Buy and maintains $19 price target.
SG
NASDAQ · SGRY
Surgery Partners, Inc.
Healthcare · Medical - Care Facilities
$15.80
Down-$1.24 (-7.85%)
Updated Sep 24, 2026, 1:35 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.08B
- P/E ratio
- -11.91
- Dividend yield
- 0.00%
- 52-week range
- $11.41 – $23.44
- Volume
- 8.15M
- Avg. volume
- 1.71M
Price performance
SGRY price history
1M range · 0 trading sessions · Daily adjusted prices
SGRY does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest SGRY news
The latest Smart Investors Daily articles mentioning SGRY.
Stock researchCompany · Overview
SGRY research
Overview
Company profile and research snapshot.
Company profile
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $20.00
- Implied upside
- —
- Analysts
- 18
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 18, 2026 | TD Cowen | Buy | — |
| Sep 14, 2026 | JP Morgan | Neutral | — |
| Aug 11, 2026 | Cantor Fitzgerald | Overweight | — |
| Aug 11, 2026 | RBC Capital | Outperform | — |
| Aug 11, 2026 | TD Cowen | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 17, 2026
Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the Transaction
BRENTWOOD, Tenn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced it has completed the previously announced sale of its ownership interests in its Idaho Falls facilities to Intermountain Health. Under the terms of the Securities Purchase Agreements, Surgery Partners received $797 million in gross proceeds and $587 million in net cash proceeds at closing, subje
Benzinga · Sep 14, 2026
Meta Platforms To $650? Here Are 10 Top Analyst Forecasts For Monday
Analysts raised price targets for Meta, IREN, Coinbase, Roblox and others; IREN and Coinbase were upgraded, while other ratings held steady.
Benzinga · Sep 14, 2026
JP Morgan Maintains Neutral on Surgery Partners, Raises Price Target to $15
JP Morgan analyst Benjamin Rossi maintains Surgery Partners (NASDAQ:SGRY) with a Neutral and raises the price target from $14 to $15.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
